These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6815075)

  • 41. Significance of fluoroquinolone-resistant Escherichia coli in urinary tract infections.
    Shigemura K; Arakawa S; Miura T; Nakano Y; Tanaka K; Fujisawa M
    Jpn J Infect Dis; 2008 May; 61(3):226-8. PubMed ID: 18503177
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Evaluation of sensitivity to antibiotics of microorganisms isolated from children with urinary tract infections].
    Cisowska A; Lewczyk E; Korzekwa K; Wojnicz D; Jankowski S; Doroszkiewicz W
    Pol Merkur Lekarski; 2003 Apr; 14(82):322-6. PubMed ID: 12868193
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Making sense of cephalosporin and amoxicillin/clavulanate susceptibility testing for uropathogens.
    Nguyen HM; Labreche MJ; Graber CJ
    Clin Infect Dis; 2014 Nov; 59(9):1349-50. PubMed ID: 25034428
    [No Abstract]   [Full Text] [Related]  

  • 44. [In vitro studies of tobramycin sensitivity of bacterial strains isolated from children treated in the Institute for Mother and Child].
    Duroś H; Nowakowska K
    Probl Med Wieku Rozwoj; 1982; 11():117-20. PubMed ID: 6817325
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vitro resistance of a 4-quinolone after two years of clinical use.
    Drlicek M; Grisold W; Armbruster C; Vetter N
    J Chemother; 1989 Jul; 1(4 Suppl):378-9. PubMed ID: 16312448
    [No Abstract]   [Full Text] [Related]  

  • 46. ["Antibiotic hierarchy" oriented antibacterial chemotherapy in urinary tract infections].
    Walther H; Meyer FP; Kiessig R; Müller GW
    Z Urol Nephrol; 1982 Dec; 75(12):879-84. PubMed ID: 7164612
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Antibiotic resistance of urinary tract infections in Sweden, 1976].
    Burman LG; Holm SE
    Lakartidningen; 1979 May; 76(21):2033-6. PubMed ID: 449477
    [No Abstract]   [Full Text] [Related]  

  • 48. Antimicrobial susceptibility pattern of clinical isolates of Pseudomonas aeruginosa.
    Al-Jasser AM; Elkhizzi NA
    Saudi Med J; 2004 Jun; 25(6):780-4. PubMed ID: 15195211
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of Etest with agar dilution for testing the susceptibility of Pseudomonas aeruginosa and other multidrug-resistant bacteria to colistin.
    Goldstein FW; Ly A; Kitzis MD
    J Antimicrob Chemother; 2007 May; 59(5):1039-40. PubMed ID: 17437963
    [No Abstract]   [Full Text] [Related]  

  • 50. Community-acquired Pseudomonas aeruginosa urinary tract infections in children hospitalized in a tertiary center: relative frequency, risk factors, antimicrobial resistance and treatment.
    Marcus N; Ashkenazi S; Samra Z; Cohen A; Livni G
    Infection; 2008 Oct; 36(5):421-6. PubMed ID: 18795227
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of three standardized disc susceptibility testing methods for colistin.
    Tan TY; Ng LS
    J Antimicrob Chemother; 2006 Oct; 58(4):864-7. PubMed ID: 16905528
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Effect of gentamicin on various bacteria strains responsible for urinary tract infections. Clinical and bacteriological results].
    Di Grazia G; Pisano A
    G Ital Chemioter; 1968; 15(4):153-7. PubMed ID: 4985841
    [No Abstract]   [Full Text] [Related]  

  • 53. [Determining the bactericidal effects of drugs and blood serum on opportunistic bacteria].
    Frolov AF; Parkhomenko LV; Lukach IG
    Vrach Delo; 1986 Mar; (3):111-3. PubMed ID: 3087061
    [No Abstract]   [Full Text] [Related]  

  • 54. Significance and characterisation of pseudomonads from urinary tract specimens.
    Taneja N; Meharwal SK; Sharma SK; Sharma M
    J Commun Dis; 2004 Mar; 36(1):27-34. PubMed ID: 16295683
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reply to Nguyen et al.
    Tamma PD; Sklansky DJ; Palazzi DL; Swami SK; Milstone AM
    Clin Infect Dis; 2014 Nov; 59(9):1351. PubMed ID: 25034420
    [No Abstract]   [Full Text] [Related]  

  • 56. In vitro susceptibility of quinolone-resistant Enterobacteriaceae uropathogens to fosfomycin trometamol, in Dakar, Senegal.
    Nabeth P; Perrier-Gros-Claude JD; Juergens-Behr A; Dromigny JA
    Scand J Infect Dis; 2005; 37(6-7):497-9. PubMed ID: 16012011
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Criteria of time and antibiotic susceptibility in the elimination of duplicates when calculating resistance frequencies.
    Rodríguez JC; Sirvent E; López-Lozano JM; Royo G
    J Antimicrob Chemother; 2003 Jul; 52(1):132-4. PubMed ID: 12805258
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Comparative study of the effect of sisomicin and other aminoglycosides on the causative agents of surgical infection].
    Navashin PS
    Antibiotiki; 1982 Dec; 27(12):26-9. PubMed ID: 6819812
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Bacterial flora in urinary tract infections of children and susceptibility to drugs].
    Pawluch D; Szozda G; Nowakowska K; Drejewicz H
    Med Dosw Mikrobiol; 1994; 46(1-2):67-71. PubMed ID: 7967933
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Increased susceptibility to colistin in hypermutable Pseudomonas aeruginosa strains from chronic respiratory infections.
    Maciá MD; Mena A; Borrell N; Pérez JL; Oliver A
    Antimicrob Agents Chemother; 2007 Dec; 51(12):4531-2. PubMed ID: 17893154
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.